Dr. Jean K. Lee, MD

Dr. Lee practices at North Shore Medical Group of the Mount Sinai School of Medicine in Greenlawn, New York.

Dr. Lee's NPI, 1548429517, was assigned on June 5, 2008. Dr. Lee graduated from Albert Einstein College of Medicine of Yeshiva University in 2008. Dr. Lee holds Rhode Island license MD20185.

Dr. Lee's primary practice is North Shore Medical Group of the Mount Sinai School of Medicine, at 5 Cuba Hill Rd, Greenlawn, NY 11740 in Suffolk County. The practice phone is (516) 536-1455.

Dr. Lee's primary practice is North Shore Medical Group of the Mount Sinai School of Medicine in Greenlawn, New York. Dr. Lee is also affiliated with The Mount Sinai Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Lee to 3 more hospitals, 5 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Lee's licenses on file in 3 states: Rhode Island, Maine and New York.

CMS data shows 258 Medicare services from Dr. Lee across 4 procedure codes in 2024, all of them office visits, for 132 Medicare patients. Medicare paid $28,041 for them. Every service was in an office.

CMS counts 132 Medicare patients who saw Dr. Lee in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have cancer, and 75% have high blood pressure. 10% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 67, with 86% women.

In 2024, Dr. Lee wrote 149 Medicare Part D claims for 62 patients. 65% of them were for generic drugs. CMS names the drug for 58 of them, across 3 drugs with 11 or more claims each, at $561,818 in total drug cost. In 2023, CMS named 46 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Lee for performance year 2024, reported through an alternative payment model (APM). Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lee as offering telehealth.

Dmand AI links 2 papers to Dr. Lee in 2017. Dr. Lee's most frequent co-authors are Ghassan K. Abou-Alfa, MD, Abraham Chachoua, MD and Bernadine R. Donahue, MD.

CMS Open Payments shows 6 general payments to Dr. Lee from 4 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $167.

Dr. Lee graduated from Albert Einstein College of Medicine of Yeshiva University in 2008.